Vadimezan (DMXAA)

Ask supplier a question | View on supplier's website

Vadimezan (DMXAA) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. DMXAA (Vadimezan) is also a STING agonist with potential antineoplastic activity. DMXAA (Vadimezan) potently induces IFN-β but relatively low TNF-α expression in vitro. DMXAA (Vadimezan) has antiviral activity. Phase 3.

Supplier	Selleck Chemicals
Product #	S1537
Sku #	S1537-25mg
Pricing	25mg, $370.00

Feedback